Shares in Novo Nordisk plunged 20% on Friday. Read More
Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints
Related Posts
Syrian regime loses Aleppo for first time since civil war began
Syria’s second-largest city Aleppo has fallen from government control for the first time since the country’s conflict began more than…
BYD founder Wang Chuanfu, fresh from his meeting with Xi Jinping, claims Chinese EVs are 3 to 5 years ahead of the competition
“Behind each of our technologies is the hard work of 110,000 engineers,” Wang said. Read More
Capital One opens new Las Vegas airport lounge, challenging Amex
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…